Latest Articles

Professor Michael Snyder performed the first longitudinal detailed integrative personal omics profile and used this to assess disease risk and monitor disease states. Technology Networks invited Snyder to an Ask Me Anything session to answer your questions about the future of digital health.

Hello and welcome to the Pulse, the monthly psychedelics industry roundup from Technology Networks and Analytical Cannabis. Here, we’ll highlight some of the most significant psychedelic industry news from the past month, including important announcements, pre-clinical work and the latest from groundbreaking psychedelic clinical trials.

Our food system is at a pivotal moment; there is enormous potential for innovation to unlock more healthy, accessible and sustainable diets for all, but we are simultaneously facing huge global challenges.

Many avenues are being explored to feed the population. While the likes of cellular agriculture still provide consumers with animal cells and the nutritional value they convey, the same cannot necessarily be said for their plant-based counterparts.

Bayesian statistics has emerged as a powerful methodology for making decisions from data in the applied sciences. Bayesian brings a new way of thinking to statistics, in how it deals with probability, uncertainty and drawing inferences from an analysis.

Kieran O'Regan, COO and co-founder of About:Energy, works to bridge the gap between universities and industry and accelerate the development of new battery technologies. Technology Networks invited Kieran O'Regan to an Ask Me Anything session to answer your questions about this incredible technology.

The gene therapy landscape is dynamic and constantly shifting. In this article, we will review major advances in disease modification for illnesses that presently still lack effective treatments, as well as some challenges and approaches to overcome them.

Though the progress of the biotech and pharma industries is nothing short of commendable, there's a high cost associated with it – its environmental impact.

In this op-ed, Professor Michael S. Kinch argues that the only way we can the COVID-19 pandemic is "to mandate that all individuals are not merely vaccinated but remain up to date with boosters."

Scientists have demonstrated the potential for using intratumoral microdevices (IMDs) to test various cancer drugs on the tumor before implementing systemic treatment. The approach could offer a hope in tackling hard-to-treat gliomas.